ICU Medical (ICUI) Downgraded by BidaskClub to “Buy”

BidaskClub lowered shares of ICU Medical (NASDAQ:ICUI) from a strong-buy rating to a buy rating in a research report sent to investors on Thursday.

Separately, Zacks Investment Research cut ICU Medical from a buy rating to a hold rating in a report on Wednesday, January 10th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of Buy and a consensus price target of $266.00.

How to Become a New Pot Stock Millionaire

Shares of ICU Medical stock opened at $251.25 on Thursday. ICU Medical has a 12 month low of $147.32 and a 12 month high of $265.27. The stock has a market cap of $5,097.11, a P/E ratio of 45.52, a PEG ratio of 2.53 and a beta of 0.36.



ICU Medical (NASDAQ:ICUI) last announced its earnings results on Thursday, March 1st. The medical instruments supplier reported $2.98 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $1.94. ICU Medical had a return on equity of 8.42% and a net margin of 5.31%. The company had revenue of $370.12 million during the quarter, compared to analysts’ expectations of $332.91 million. During the same period last year, the business posted $1.20 EPS. ICU Medical’s revenue for the quarter was up 286.8% on a year-over-year basis. equities analysts anticipate that ICU Medical will post 6.29 earnings per share for the current fiscal year.

In other ICU Medical news, Director George A. Lopez sold 7,640 shares of the stock in a transaction dated Wednesday, March 21st. The stock was sold at an average price of $253.83, for a total value of $1,939,261.20. Following the sale, the director now owns 526,574 shares of the company’s stock, valued at approximately $133,660,278.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director George A. Lopez sold 26,475 shares of the stock in a transaction dated Wednesday, April 4th. The shares were sold at an average price of $246.73, for a total value of $6,532,176.75. Following the completion of the sale, the director now directly owns 494,025 shares in the company, valued at approximately $121,890,788.25. The disclosure for this sale can be found here. Insiders sold a total of 55,452 shares of company stock worth $13,775,146 in the last ninety days. 12.50% of the stock is owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the business. Suntrust Banks Inc. raised its position in ICU Medical by 1.7% in the 4th quarter. Suntrust Banks Inc. now owns 14,617 shares of the medical instruments supplier’s stock valued at $3,157,000 after purchasing an additional 239 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in ICU Medical by 2.2% in the 4th quarter. The Manufacturers Life Insurance Company now owns 11,603 shares of the medical instruments supplier’s stock valued at $2,505,000 after purchasing an additional 245 shares in the last quarter. Public Employees Retirement Association of Colorado raised its position in ICU Medical by 0.3% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 100,334 shares of the medical instruments supplier’s stock valued at $21,672,000 after purchasing an additional 254 shares in the last quarter. Profund Advisors LLC raised its position in ICU Medical by 18.1% in the 4th quarter. Profund Advisors LLC now owns 1,804 shares of the medical instruments supplier’s stock valued at $390,000 after purchasing an additional 276 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in ICU Medical by 39.2% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 984 shares of the medical instruments supplier’s stock valued at $213,000 after purchasing an additional 277 shares in the last quarter. 76.73% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This news story was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://stocknewstimes.com/2018/04/23/icu-medical-icui-downgraded-by-bidaskclub-to-buy.html.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply